NONALCOHOLIC FATTY LIVER DISEASE: CLINICAL FEATURES,DIAGNOSIS AND OUTCOMES

Авторы

  • L.I. Makhmudova Автор

DOI:

https://doi.org/10.5281/zenodo.20511832

Ключевые слова:

NAFLD, insulin resistance, HOMA-IR, steatosis, metabolic syndrome, fibrosis

Аннотация

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder worldwide, strongly associated with obesity, insulin resistance, and metabolic syndrome. The disease ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. This study evaluates clinical, laboratory, and instrumental findings in patients with NAFLD and assesses metabolic risk factors associated with disease severity.

NINE muqovasi

Загрузки

Опубликован

2026-06-02

Выпуск

Том 3 № 6 (2026): Июнь 2026

Раздел

Articles

Лицензия

Copyright (c) 2026 The author(s)

Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.

Как цитировать

NONALCOHOLIC FATTY LIVER DISEASE: CLINICAL FEATURES,DIAGNOSIS AND OUTCOMES. (2026). New Innovations in National Education, 3(6). https://doi.org/10.5281/zenodo.20511832

Библиографические ссылки

1. Younossi ZM et al. Global epidemiology of NAFLD. Hepatology. 2020.

2. Eslam M, Newsome PN. MAFLD concept and metabolic dysfunction. J Hepatol. 2020.

3. Loomba R, Adams LA. Advances in NAFLD diagnosis. Nat Rev Gastroenterol Hepatol. 2021.

4. Byrne CD, Targher G. NAFLD as multisystem disease. J Hepatol. 2018–2021.

5. Tilg H, Effenberger M. Insulin resistance in NAFLD. Hepatology. 2020.

6. Angulo P et al. Natural history of NAFLD. Gastroenterology. 2019.

7. European Association for the Study of the Liver (EASL) guidelines. 2021.